bioRxivNeurosciencePreprint
Human and mouse iPSC-derived astrocyte subtypes reveal vulnerability in Vanishing White Matter
Prisca S. LeferinkiD, Stephanie DoovesiD, Anne E.J. HilleniD, Kyoko WatanabeiD, Gerbren Jacobs, Lisa Gasparotto, Paulien Cornelissen‐Steijger, Marjo S. van der KnaapiD, Vivi Majella HeineiD
Abstract
Astrocytes gained attention as important players in neurological disease, including a number of leukodystrophies. Several studies explored the generation of induced pluripotent stem cell-derived astrocytes for drug screening and regenerative studies. Developing robust models of patient induced pluripotent stem cells is challenged by high variability due to diverse genetic backgrounds and long-term culture procedures. While human models are of special interest, mouse-based models have the advantage that for them these issues are less pronounced. Here we present astrocyte differentiation protocols for both human and mouse induced pluripotent stem cells to specifically induce grey and white matter astrocytes. Both subtypes expressed astrocyte-associated markers, had typical astrocyte morphologies, and gave a reactive response to stress. Importantly, the grey and white matter-like astrocytes differed in size, complexity of processes, and expression profile, conform primary grey and white matter astrocytes. The newly presented mouse and human stem cell-based models for the leukodystrophy Vanishing White Matter replicated earlier findings, such as increased proliferation, decreased OPC maturation and modulation by hyaluronidase. We studied intrinsic astrocyte subtype vulnerability in Vanishing White Matter in both human and mouse cells. Oligodendrocyte maturation was specifically inhibited in cultures with Vanishing White Matter white matter-like astrocytes. By performing RNA sequencing, we found more differentially regulated genes in the white than in the grey matter-like astrocytes. Human and mouse astrocytes showed the same affected pathways, although human white matter-like astrocytes presented human-specific disease mechanisms involved in Vanishing White Matter. Using both human and mouse induced pluripotent stem cells, our study presents protocols to generate white and grey matter-like astrocytes, and shows astrocyte subtype-specific defects in Vanishing White Matter. While mouse induced pluripotent stem cell-based cultures may be less suitable to mimic human astrocyte subtype- or patient-specific changes, they might more robustly represent disease mutation-related cellular phenotypes as the cells are derived from inbred mice and the protocols are faster. The presented models give new tools to generate astrocyte subtypes for in vitro disease modeling and in vivo regenerative applications.
- organism: human
- organism: mouse
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid generation of ventral spinal cord-like astrocytes from human iPSCs for modeling non-cell autonomous mechanisms of lower motor neuron disease
Vincent Soubannier, Mathilde Chaineau, … Stefano Stifani·CellsPeer-reviewed·Jan 24, 2022
- Varicose-projection astrocytes: a reactive phenotype associated with neuropathology
Caterina Ciani, Giulio Pistorio, … Carmen Falcone·bioRxiv·Mar 17, 2025
- Generation of star-shaped human induced astrocytes with a mature inflammatory phenotype for CNS disease modeling
Dimitrios Voulgaris, Polyxeni Nikolakopoulou, Anna Herland·Stem Cell Reviews and ReportsPeer-reviewed·Apr 30, 2022
- MLC1 alteration in iPSCs give rise to disease-like cellular vacuolation phenotype in the astrocyte lineage
Saumya Sharma, Vishal Bharti, … Debojyoti Chakraborty·Orphanet Journal of Rare DiseasesPeer-reviewed·Mar 26, 2026
- Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery
Vincent Soubannier, Gilles Maussion, … Stefano Stifani·Neuroscience LettersPeer-reviewed·May 4, 2020
- iPSC-Astrocyte morphology reflects patient clinical markers
Helen A. Rowland, Georgina Miller, … Noel J. Buckley·bioRxiv·Jul 15, 2023